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In the 1980s minimally invasive surgical techniques 
were booming across many disciplines, cutting postoperative 
recovery time by reducing postoperative pain, hospital length 
of stay and need for blood transfusion. Expansion, however, 
was limited by the complexity of  surgery that could be 
achieved with the technical limitations that laparoscopic 
instruments present. Robotic technology, initially developed 
by defense organisations for remote operating, of fers 
solutions to these limitations including 3-dimensional 
(3D) view of the operating field, filtering of physiological 
tremor, and articulate arms allowing greater precision and 
control. The opportunity to combine robotic technology with 
laparoscopic surgery was seized by commercial platforms, 
and allows increasingly complex procedures to be achieved 
with minimally invasive techniques.
In 1999, Intuitive Surgical (Sunnyvale, CA, USA) 
launched the da Vinci robot, a ‘master-slave’ device with a 
console controlled by the surgeon and robotic arms installed 
on a patient bedside cart. In 2003, Intuitive Surgical acquired 
its main competitor Computer Motion and has since 
dominated the market. Four generations of da Vinci robot 
later, and over 4,000 units sold worldwide, the da Vinci robot 
is the focus of >10,000 peer-reviewed publications examining 
the use of robotics in surgery.
Urologists have been at the forefront in harnessing the 
power of robotic technology to advance their surgical field. 
Robotic assisted prostatectomy, cystectomy, pyeloplasty, 
nephrectomy, and partial nephrectomy are all increasingly 
common techniques. More recently, a robotic device for 
endourological procedures has been trialed in humans [1].
Widespread introduction of surgical robots in urology 
occurred from the year 2000 onwards in the belief  that 
they provided benefit to surgical outcomes over existing 
techniques. Concerns have been raised over the lack of high-
level evidence to support the use of surgical robotic systems, 
considering the substantial additional costs they introduce [2].
Randomized controlled trial evidence comparing robot-
assisted radical prostatectomy over an open retropubic 
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approach failed to show any difference between urogenital 
or early oncological outcomes at 6, 12, or 24 weeks [3]. 
However the study did demonstrate a shorter operating 
time, reduced length of stay and estimated total blood loss 
[3]. While there are clear benefits of a robotic approach over 
open surgery in terms of short-term perioperative morbidity, 
the significant extra costs introduced by the robot are still 
questioned, and restrict expansion.
COST AND COMPETITION
The high cost associated with robotic surgery was 
partly explained by Intuitive Surgical being the sole 
producer of  commercial robotic surgical systems. In 2019 
a number of  their intellectual property patents are due 
to expire. Competing master-slave system Telelap Alf-X 
by TransEnterix has now entered the market with sales 
made in Italy and Japan, and has an application with the 
U.S. Food and Drug Administration pending. Several other 
systems are also expected to be marketed within the next 5 
years [4]. Increased competition, reusable instruments, and a 
resulting reduction in cost will lead to a stronger economic 
argument for robotic-assisted surgery, and expansion to 
more centers and regions is likely.
OPEN CONSOLES
The closed console of da Vinci  envelops the surgeon’s 
face and compromises his or her situational awareness 
within the operating theatre. Telelap Alf-X and the newer 
Revo-I, currently undergoing trials in Korea [5], promise open 
surgeon consoles with the potential to improve operating 
ergonomics. The Telelap Alf-X monitor requires the surgeon 
to wear 3D glasses and incorporates eye-tracking, whereas 
Revo-I boasts a 3D high definition monitor [4].
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HAPTIC FEEDBACK
A major limitation of robotic surgical systems was the 
lack of haptic feedback compared to traditional laparoscopic 
technique. Telelap Alf-X  is the first commercial robotic 
platform to incorporate haptic feedback technology. Via 
counter-movement of  the console handles, the surgeon 
receives tactile information regarding force and its direction 
applied at the surgical site. Haptic feedback while operating 
increases surgical awareness and improves security.
SINGLE PORT SURGERY
Laparo-endoscopic single-site surgery (LESS) robotic 
systems are emerging technologies that allow multiple 
instruments and a camera to be inserted via a single incision. 
These robots further advance minimally invasive techniques, 
reducing surgical trauma and when an umbilical incision is 
used, approach scar-free operating. While experimental trials 
will be required to establish the benefit of LESS, they are 
expected to widen the gap between traditional and robotic 
surgical techniques. Both master-slave and bedside devices 
are being developed with Intuitive Surgical launching the 
SP 1098 single port platform for da Vinci, and competing 
systems from Titan Medical and TransEnterix [4].
BEYOND SURGICAL DEVICES
Robotics in medicine is not limited to surgical devices. 
One of the greatest healthcare challenges of the developed 
world is combating preventable disease caused by poor 
lifestyle choices. Researchers at the University of Southern 
California are developing socially assistive robots that 
interact with individuals to coach and motivate them 
towards a health or wellbeing goal [6]. With a call from the 
National Institutes of  Health for research proposals for 
socially assistive robots, this field has potential to change 
management of difficult social issues such as weight loss 
and smoking cessation. If such goals are realized, socially 
assistive robots could be utilized to optimize perioperative 
comorbidities and thus improve surgical outcomes.
CONCLUSIONS
A range of competing robotic surgical systems is expected 
to enter the market in the next 5 years. The new technology 
offered has the potential to improve surgical ergonomics. 
With the market dominated by the high-performing but 
expensive generations of the da Vinci for almost 20 years, 
newer, economic machines may make robotic surgery 
accessible to wider populations.
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